These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 4617660
1. Sinemet. Drug Ther Bull; 1974 Oct 11; 12(21):83-4. PubMed ID: 4617660 [No Abstract] [Full Text] [Related]
2. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report. Savery F. Curr Ther Res Clin Exp; 1976 Mar 11; 19(3):337-8. PubMed ID: 817863 [No Abstract] [Full Text] [Related]
3. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. Londoõ R. Neurol Neurocir Psiquiatr; 1976 Mar 11; 17(4):293-300. PubMed ID: 1018729 [Abstract] [Full Text] [Related]
4. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment]. Martínez-Lage JM, Burguera JA, Deldago G, Zubieta JL. Arch Neurobiol (Madr); 1978 Mar 11; 41(1):3-18. PubMed ID: 697513 [No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Lombardo L, De la Garza R. Arch Invest Med (Mex); 1977 Mar 11; 8(2):123-8. PubMed ID: 907417 [Abstract] [Full Text] [Related]
6. [The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients]. Völler GW, Deze J. ZFA (Stuttgart); 1976 Mar 10; 52(7):380-8. PubMed ID: 773025 [No Abstract] [Full Text] [Related]
7. Sinemet CR for Parkinson's disease. Med Lett Drugs Ther; 1991 Oct 04; 33(854):92-3. PubMed ID: 1895993 [No Abstract] [Full Text] [Related]
8. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE, Tolosa ES, Loewenson RB, Lee MC, Resch JA, Baker AB. Geriatrics; 1975 Dec 04; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
10. L-dopa and carbidopa (sinemet) in the management of parkinsonism. Critchley E. Postgrad Med J; 1975 Sep 04; 51(599):619-21. PubMed ID: 1105500 [Abstract] [Full Text] [Related]
11. What to do when Sinemet fails: Part one. Klawans HL. Clin Neuropharmacol; 1984 Sep 04; 7(2):121-33. PubMed ID: 6733692 [No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study]. Hayek J. Schweiz Med Wochenschr; 1977 Apr 09; 107(14):474-9. PubMed ID: 847450 [Abstract] [Full Text] [Related]
13. Madopar versus sinemet. A clinical study on their effectiveness. Korten JJ, Keyser A, Joosten EM, Gabreëls FJ. Eur Neurol; 1975 Apr 09; 13(2):65-71. PubMed ID: 1095374 [Abstract] [Full Text] [Related]
16. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Lieberman A, Goodgold A, Jonas S, Leibowitz M. Neurology; 1975 Oct 09; 25(10):911-6. PubMed ID: 1101099 [Abstract] [Full Text] [Related]
17. Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial. Pakkenberg H, Birket-Smith E, Dupont E, Hansen E, Mikkelsen B, Presthus J, Rautakorpi I, Riman E, Rinne UK. Acta Neurol Scand; 1976 May 09; 53(5):376-85. PubMed ID: 1266576 [Abstract] [Full Text] [Related]
18. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records]. Szulc-Kuberska J, Niewodniczy A, Poźniak-Patewics E, Wolczyk-Orzechowska M. Neurol Neurochir Pol; 1975 May 09; 9(5):611-5. PubMed ID: 1186952 [Abstract] [Full Text] [Related]
19. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Gawel M, Riopelle R, Libman I, Bouchard S. Adv Neurol; 1987 May 09; 45():535-8. PubMed ID: 3548263 [No Abstract] [Full Text] [Related]
20. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)]. Hanzal F. MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]